1

Genscript Biotech

#3809

Rank

$2.59B

Marketcap

CN China

Country

Genscript Biotech
Leadership team

Mr. Jiange Meng (Chairman)

Dr. Zhenyu Liu (Chief Exec. Officer)

Ms. Ye Wang M.S. (Co-Founder, Pres & Exec. Director)

Products/ Services
Biotechnology, Genetics, Manufacturing
Number of Employees
1,000 - 20,000
Headquarters
Piscataway, New Jersey, United States
Established
2002
Revenue
500M - 1B
Traded as
1548.HK
Social Media
Overview
Location
Summary
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. It operates through four segments: Life Science Services and Products, Biologics Development Services, Industrial Synthetic Biology Products, and Cell Therapy. The Life Science Services and Products segment provides research services in various categories, including gene synthesis and molecular cloning, oligonucleotide synthesis, protein engineering, peptide synthesis, antibody development, molecular diagnostics tools, and genome editing materials for use in basic biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine, agriculture, environmental studies, and food industry. The Biologics Development Services segment offers various services, such as antibody drug discovery, antibody drug pre-clinical and clinical development, plasmid and virus pre-clinical development, and plasmid and virus clinical development for therapeutic antibodies, as well as gene and cell therapy development and biologics discovery and development services for pharmaceutical, biotech, government, and academic customers. The Industrial Synthetic Biology Products segment constructs non-pathogenic microbial strains; and develops and produces industrial enzymes for food processing, feed, pharmaceutical, and chemical industries. The Cell Therapy segment discovers and develops chimeric antigen receptor T-cell therapies for the treatment of liquid and solid tumors. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the People's Republic of China.
History

Genscript Biotech Corporation was founded in 2002 as a spinoff of Global Bio-chem Technology (GBT). Headed by Dr. Jiang Xu and Dr. J.J. Wang, Genscript has since developed into a leading global biotechnology company providing a wide array of products and services for the life science industry. Genscript is engaged in drug discovery and development, immune cell/cancer cell/microbiome sequencing as well as other related services. Genscript also provides contract research services, such as chemical synthesis, sequence analysis, CRISPR screening, Epigenetic gene regulation, lenti-CRISPR library development and more.

Mission
Genscript’s mission is to help turn ideas into reality. Inspiring and empowering life science researchers to bring the medical treatments, sustainable food and clean energy of tomorrow to life.
Vision
Our vision is to create a world of increased health and wellness through science, technology and collaboration.
Key Team

Mr. Shiniu Wei (Chief Financial Officer)

Ms. Weihui Shao (Chief Operating Officer)

Dr. Li Zhu Ph.D. (Chief Strategy Officer & Exec. Director)

Mr. Chifa Zhang (Department Head of Industry Synthetic Biology Product Segment)

Dr. Brian Hosung Min (CEO of Biologics Bus.)

Dr. Chuan-Chu Chou (Head of Discovery and Preclinical Services)

Ms. Wai Ling Wong A.C.I.S., A.C.S., ACIS, ACS (Company Sec.)

References
Genscript Biotech
Leadership team

Mr. Jiange Meng (Chairman)

Dr. Zhenyu Liu (Chief Exec. Officer)

Ms. Ye Wang M.S. (Co-Founder, Pres & Exec. Director)

Products/ Services
Biotechnology, Genetics, Manufacturing
Number of Employees
1,000 - 20,000
Headquarters
Piscataway, New Jersey, United States
Established
2002
Revenue
500M - 1B
Traded as
1548.HK
Social Media